Trial in Progress: An Open-Label, Multi-Center, First in Human, Phase 1/2a Trial to Evaluate the Safety and Preliminary Efficacy of Autologous Tolerogenic Dendritic Cells Ex Vivo Loaded with Recombinant Factor VIII (FVIII) in Adults with Congenital Hemophilia a (HA) with Neutralizing Antibodies to FVIII and Having Failed Immune Tolerance Induction (ITI)

Subjects

Subjects :

Immunology
Cell Biology
Hematology
Biochemistry

Details

ISSN :

15280020 and 00064971

Volume :

140

Database :

OpenAIRE

Journal :

Blood

Accession number :

edsair.doi...........c23352af869f327aac3adc574f0ce519